Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000–2016

Targeted therapies (TT) and immune checkpoint inhibitors (ICI) have become increasingly important in the treatment of metastatic malignant melanoma in recent years. We examined implementation and effectiveness of these new therapies over time in Germany with a focus on regional differences. We analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hellmund, Peter, Schmitt, Jochen, Roessler, Martin, Meier, Friedegund, Schoffer, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565277/
https://www.ncbi.nlm.nih.gov/pubmed/32825357
http://dx.doi.org/10.3390/cancers12092354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565277/
https://www.ncbi.nlm.nih.gov/pubmed/32825357
http://dx.doi.org/10.3390/cancers12092354

Ejemplares similares